# Nonclinical Safety Evaluation of Reformulated Drug Products and Products Intended for Administration by an Alternate Route - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/nonclinical-safety-evaluation-of-reformulated-drug-products-and-products-intended-for-administration-by-an-alternate-route/4ff25d70-5ac4-418c-a83e-79f958421f2c

> FDA guidance document: Nonclinical Safety Evaluation of Reformulated Drug Products and Products Intended for Administration by an Alternate Route. Issue date: October 28, 2015. Get complete insights and analysis.

---

## Details

- Title: Nonclinical Safety Evaluation of Reformulated Drug Products and Products Intended for Administration by an Alternate Route
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2015-10-28
- Last Changed: 2020-05-14
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2008-D-0142">FDA-2008-D-0142</a>

## Related Documents

- [Osteoporosis:  Nonclinical Evaluation of Drugs Intended for Treatment Guidance for Industry:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/osteoporosis-nonclinical-evaluation-of-drugs-intended-for-treatment-guidance-for-industry-guidance-for-industry/8305ef9e-7edf-412b-bb46-28ef3a7f9493)
- [Uncomplicated Gonorrhea: Developing Drugs for Treatment](https://www.globalkeysolutions.net/guidances/guidance-document/uncomplicated-gonorrhea-developing-drugs-for-treatment/56891f77-fa9d-4c61-87e8-d129790d9d35)
- [Nonclinical Evaluation of Endocrine-Related Drug Toxicity](https://www.globalkeysolutions.net/guidances/guidance-document/nonclinical-evaluation-of-endocrine-related-drug-toxicity/3925c81a-41d1-4ab8-a0da-0aec3f634c05)